BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tundo A, Filippis R, Proietti L. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience. World J Psychiatr 2015; 5(3): 330-341 [PMID: 26425446 DOI: 10.5498/wjp.v5.i3.330]
URL: https://www.wjgnet.com/2220-3206/full/v5/i3/330.htm
Number Citing Articles
Yuncheng Zhu, Xiaohui Wu, Rubai Zhou, Oliver Sie, Zhiang Niu, Fang Wang, Yiru Fang. Hypothalamic-Pituitary-End-Organ Axes: Hormone Function in Female Patients with Major Depressive DisorderNeuroscience Bulletin 2021; 37(8): 1176 doi: 10.1007/s12264-021-00689-6
Yiwen Cheng, Jiaming Liu, Zongxin Ling. Short-chain fatty acids-producing probiotics: A novel source of psychobioticsCritical Reviews in Food Science and Nutrition 2022; 62(28): 7929 doi: 10.1080/10408398.2021.1920884
Hansal Bhachech, Kamal Nath, Roop Sidana, Nilesh Shah, Rajesh Nagpal, R. Sathianathan, Ashutosh Kakkad, Krishnaprasad Korukonda. Personalized Approach in the Management of Difficult-to-Treat and Treatment-Resistant Depression With Second-Generation Antipsychotics: A Delphi StatementCureus 2024;  doi: 10.7759/cureus.52878
Norma Angélica Labra Ruiz, Daniel Santamaría Del Ángel, Norma Osnaya Brizuela, Armando Valenzuela Peraza, Hugo Juárez Olguín, Mónica Punzo Soto, David Calderón Guzmán. Inflammatory Process and Immune System in Major Depressive DisorderInternational Journal of Neuropsychopharmacology 2022; 25(1): 46 doi: 10.1093/ijnp/pyab072
Jia Liu, Xin Xu, Qiang Luo, Ya Luo, Ying Chen, Su Lui, Min Wu, Hongyan Zhu, Graham J. Kemp, Qiyong Gong. Brain grey matter volume alterations associated with antidepressant response in major depressive disorderScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10676-5
Xuexiao Shao, Danfeng Yan, Wenwen Kong, Shuting Sun, Mei Liao, Wenwen Ou, Yan Zhang, Fang Zheng, Xiaowei Li, Lingjiang Li, Bin Hu. Brain function changes reveal rapid antidepressant effects of nitrous oxide for treatment-resistant depression:Evidence from task-state EEGPsychiatry Research 2023; 322: 115072 doi: 10.1016/j.psychres.2023.115072
Julio Bobes, Jerónimo Saiz-Ruiz, Víctor Pérez. Barriers to complete recovery of major depression: Cross-sectional, multi-centre study on clinical practice. RECORD studyRevista de Psiquiatría y Salud Mental (English Edition) 2019; 12(3): 141 doi: 10.1016/j.rpsmen.2018.10.002
Pallab Bhattacharyya, Amit Anand, Jian Lin, Murat Altinay. Left Dorsolateral Prefrontal Cortex Glx/tCr Predicts Efficacy of High Frequency 4- to 6-Week rTMS Treatment and Is Associated With Symptom Improvement in Adults With Major Depressive Disorder: Findings From a Pilot StudyFrontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.665347
Zuleide M. Ignácio, Gislaine Z. Réus, Helena M. Abelaira, Airam B. de Moura, Thays G. de Souza, Danyela Matos, Mariana P. Goldim, Khiany Mathias, Leandro Garbossa, Fabricia Petronilho, João Quevedo. Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brainMetabolic Brain Disease 2017; 32(4): 1195 doi: 10.1007/s11011-017-0028-y
Takuwa Yasuda, Yasuhiro Kashima. A soy protein enzymatic digest mitigates Nrf2-related oxidative stress and attenuates depression-like behavior in a mouse model of sub-chronic restraint stressHeliyon 2024; 10(6): e27826 doi: 10.1016/j.heliyon.2024.e27826
Lucia Carboni, Francesca Pischedda, Giovanni Piccoli, Mario Lauria, Laura Musazzi, Maurizio Popoli, Aleksander A. Mathé, Enrico Domenici. Depression-Associated Gene Negr1-Fgfr2 Pathway Is Altered by Antidepressant TreatmentCells 2020; 9(8): 1818 doi: 10.3390/cells9081818
Jasmina Mallet, Philip Gorwood, Yann Le Strat, Caroline Dubertret. Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A ReviewInternational Journal of Neuropsychopharmacology 2019; 22(10): 651 doi: 10.1093/ijnp/pyz043
Marco Solmi, Nicola Veronese, Leonardo Zaninotto, Marc L. M. van der Loos, Keming Gao, Ayal Schaffer, Catherine Reis, Claus Normann, Ion-George Anghelescu, Christoph U. Correll. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trialsCNS Spectrums 2016; 21(5): 403 doi: 10.1017/S1092852916000523
Michele Tufano, Graziano Pinna. Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?Molecules 2020; 25(5): 1062 doi: 10.3390/molecules25051062
Rodolfo Savica, Brandon R. Grossardt, James H. Bower, J. Eric Ahlskog, Michelle M. Mielke, Walter A. Rocca. Incidence and time trends of drug-induced parkinsonism: A 30-year population-based studyMovement Disorders 2017; 32(2): 227 doi: 10.1002/mds.26839
měli bychom zhodnotit diagnostické aspekty, hlavně komorbiditu a adekvátnost dosavadní léčby včetně adherence.. Pharmacoresistant depression - what is the next step?Psychiatrie pro praxi 2016; 17(3): 92 doi: 10.36290/psy.2016.025
Antonio Tundo, Laura Musetti, Claudia Del Grande, Rocco de Filippis, Luca Proietti, Erika Cambiali, Caterina Franceschini, Liliana Dell'Osso. Is short‐term antidepressant treatment effective and safe in bipolar depression? Results from an observational multicenter studyHuman Psychopharmacology: Clinical and Experimental 2021; 36(3) doi: 10.1002/hup.2773
Horacio A. Capote, Michelle Rainka, Erica S. Westphal, Jonathan Beecher, Francis M. Gengo. Ropinirole in Bipolar Disorder: Rate of Manic Switching and Change in Disease SeverityPerspectives in Psychiatric Care 2018; 54(2): 100 doi: 10.1111/ppc.12205
Md Harunur Rashid, Dinesh Babu, Newton Tran, Béla Reiz, Arno G. Siraki. Neutrophil Myeloperoxidase-Mediated N-Demethylation of Quetiapine Leads to N-Desalkylquetiapine, a Pharmacologically Active Cytochrome P450 MetaboliteChemical Research in Toxicology 2022; 35(6): 1001 doi: 10.1021/acs.chemrestox.2c00008
Zuleide Maria Ignácio, Ana Valquíria Calixto, Ritele Hernandez da Silva, João Quevedo, Gislaine Zilli Réus. The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studiesNeuroscience & Biobehavioral Reviews 2018; 86: 36 doi: 10.1016/j.neubiorev.2017.12.012
Antonio Tundo, Laura Musetti, Rocco de Filippis, Claudia Del Grande, Valentina Falaschi, Luca Proietti, Liliana Dell'Osso. Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disordersJournal of Affective Disorders 2019; 245: 819 doi: 10.1016/j.jad.2018.11.024
Antonio Tundo, Sophia Betro’, Rocco de Filippis, Fulvia Marchetti, Daniele Nacca, Roberta Necci, Marica Iommi. Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-AnalysisLife 2023; 13(4): 1043 doi: 10.3390/life13041043
Jon E. Grant, Sarah A. Redden, Eric W. Leppink. Double-blind switch study of vilazodone in the treatment of major depressive disorderInternational Clinical Psychopharmacology 2017; 32(3): 121 doi: 10.1097/YIC.0000000000000166
Liangcai Gao, Xinnan Liu, Li Yu, Junlin Wu, Mingchu Xu, Yusi Liu. Folic acid exerts antidepressant effects by upregulating brain-derived neurotrophic factor and glutamate receptor 1 expression in brainNeuroReport 2017; 28(16): 1078 doi: 10.1097/WNR.0000000000000887
Nicholas L. Bormann, Tyler S. Oesterle, Stephan Arndt, Victor M. Karpyak, Paul E. Croarkin. Systematic review and meta‐analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disordersThe American Journal on Addictions 2024; 33(3): 269 doi: 10.1111/ajad.13517
Antonio Tundo, Sophia Betro', Marica Iommi, Rocco de Filippis. Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort studyProgress in Neuro-Psychopharmacology and Biological Psychiatry 2022; 112: 110425 doi: 10.1016/j.pnpbp.2021.110425
Éva Borbély, Mária Simon, Eberhard Fuchs, Ove Wiborg, Boldizsár Czéh, Zsuzsanna Helyes. Novel drug developmental strategies for treatment‐resistant depressionBritish Journal of Pharmacology 2022; 179(6): 1146 doi: 10.1111/bph.15753
Antonio Tundo, Laura Musetti, Sophia Betrò, Erika Cambiali, Rocco de Filippis, Donatella Marazziti, Federico Mucci, Luca Proietti, Liliana Dell’Osso. Are anxious and mixed depression two sides of the same coin? Similarities and differences in patients with bipolar I, II and unipolar disordersEuropean Psychiatry 2023; 66(1) doi: 10.1192/j.eurpsy.2023.2445
Nobue Kitanaka, Frank Scott Hall, George Richard Uhl, Junichi Kitanaka. Lithium Pharmacology and a Potential Role of Lithium on Methamphetamine Abuse and DependenceCurrent Drug Research Reviews 2019; 11(2): 85 doi: 10.2174/2589977511666190620141824
Sana Tafseer, Rachna Gupta, Rafat Ahmad, Seema Jain, M.S. Bhatia, Lalit K. Gupta. Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorderPharmacology Biochemistry and Behavior 2021; 200: 173073 doi: 10.1016/j.pbb.2020.173073
Wenhui Lei, Yiwen Cheng, Jie Gao, Xia Liu, Li Shao, Qingming Kong, Nengneng Zheng, Zongxin Ling, Weiming Hu. Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1224155
Jasmin Obermanns, Vera Flasbeck, Saskia Steinmann, Georg Juckel, Barbara Emons. Investigation of the Serotonergic Activity and the Serotonin Content in Serum and Platelet, and the Possible Role of the Serotonin Transporter in Patients with DepressionBehavioral Sciences 2022; 12(6): 178 doi: 10.3390/bs12060178
Chih-Ken Chen, Shu-Yu Yang, Seon-Cheol Park, Ok-Jin Jang, Xiaomin Zhu, Yu-Tao Xiang, Wen-Chen Ouyang, Afzal Javed, M. Nasar Sayeed Khan, Sandeep Grover, Ajit Avasthi, Roy Abraham Kallivayalil, Kok Yoon Chee, Norliza Chemi, Takahiro A. Kato, Kohei Hayakawa, Pornjira Pariwatcharakul, Margarita Maramis, Lakmi Seneviratne, Kang Sim, Wai Kwong Tang, Tin Oo, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Yong Chon Park, Naotaka Shinfuku, Shih-Ku Lin. Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS studyAsian Journal of Psychiatry 2023; 85: 103613 doi: 10.1016/j.ajp.2023.103613
Motohiro Okada, Kouji Fukuyama, Eishi Motomura. Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of QuetiapineInternational Journal of Molecular Sciences 2022; 23(16): 9103 doi: 10.3390/ijms23169103
Julio Bobes, Jerónimo Saiz-Ruiz, Víctor Pérez. Barreras para la recuperación completa en la depresión mayor: estudio transversal multicéntrico en la práctica clínica. Estudio RECORDRevista de Psiquiatría y Salud Mental 2019; 12(3): 141 doi: 10.1016/j.rpsm.2018.10.002
A. Tundo, R. de Filippis, F. De Crescenzo. Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta‐analysisActa Psychiatrica Scandinavica 2019; 140(2): 116 doi: 10.1111/acps.13055
Marlene P. Freeman, George I. Papakostas, Bettina Hoeppner, Erica Mazzone, Heidi Judge, Cristina Cusin, Sanjay Mathew, Gerard Sanacora, Dan Iosifescu, Charles DeBattista, Madhukar H. Trivedi, Maurizio Fava. Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depressionJournal of Psychiatric Research 2019; 110: 166 doi: 10.1016/j.jpsychires.2019.01.010
Mohammed T. Abou-Saleh, Bruno Müller-Oerlinghausen, Alec J. Coppen. Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depressionInternational Journal of Bipolar Disorders 2017; 5(1) doi: 10.1186/s40345-017-0080-x
Lu Yang, Yousong Su, Sijia Dong, Tao Wu, Yongjing Zhang, Hong Qiu, Wenjie Gu, Hong Qiu, Yifeng Xu, JianLi Wang, Jun Chen, Yiru Fang. Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in ChinaFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.954973
Antoine Yrondi, Hervé Javelot, Bénédicte Nobile, Ludivine Boudieu, Bruno Aouizerate, Pierre-Michel Llorca, Thomas Charpeaud, Djamila Bennabi, Antoine Lefrere, Ludovic Samalin. French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024L'Encéphale 2024;  doi: 10.1016/j.encep.2023.11.029
Gernot Fugger, Markus Dold, Lucie Bartova, Alexander Kautzky, Daniel Souery, Julien Mendlewicz, Alessandro Serretti, Joseph Zohar, Stuart Montgomery, Richard Frey, Siegfried Kasper. Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)European Neuropsychopharmacology 2018; 28(6): 752 doi: 10.1016/j.euroneuro.2018.03.011
Thomas RE Barnes, Richard Drake, Carol Paton, Stephen J Cooper, Bill Deakin, I Nicol Ferrier, Catherine J Gregory, Peter M Haddad, Oliver D Howes, Ian Jones, Eileen M Joyce, Shôn Lewis, Anne Lingford-Hughes, James H MacCabe, David Cunningham Owens, Maxine X Patel, Julia MA Sinclair, James M Stone, Peter S Talbot, Rachel Upthegrove, Angelika Wieck, Alison R Yung. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology 2020; 34(1): 3 doi: 10.1177/0269881119889296
Francisco López-Muñoz, Cecilio Álamo, Pilar García-García. Melatonin, Neuroprotective Agents and Antidepressant Therapy2016; : 421 doi: 10.1007/978-81-322-2803-5_28
Jari Tiihonen, Antti Tanskanen, Fabian Hoti, Pia Vattulainen, Heidi Taipale, Juha Mehtälä, Markku Lähteenvuo. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort studyThe Lancet Psychiatry 2017; 4(7): 547 doi: 10.1016/S2215-0366(17)30134-7
Liwei Liao, Zhiguo Wu, David Mellor, Daihui Peng, Chen Zhang, Jingjing Xu, Chenglei Wang, Lvchun Cui, Yiru Fang. Subtypes of treatment-resistant depression determined by a latent class analysis in a Chinese clinical populationJournal of Affective Disorders 2019; 249: 82 doi: 10.1016/j.jad.2019.02.005
Dian-Jeng Li, Ping-Tao Tseng, Yen-Wen Chen, Ching-Kuan Wu, Pao-Yen Lin. Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other AntidepressantsMedicine 2016; 95(13): e3165 doi: 10.1097/MD.0000000000003165
Yanbo Zhang, Xiaoying Bi, Olubunmi Adebiyi, Junhui Wang, Ali Mooshekhian, Jacob Cohen, Zelan Wei, Fei Wang, Xin-Min Li. Venlafaxine Improves the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and Neuroinflammation in the BrainFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00332
Javier Porras-Ramírez, Rosa Estrada-Reyes, José Salud Rodríguez-Zavala, Ana Maria Dorantes-Barrón, Noé Jurado-Hernández, Mariano Martínez-Vázquez. Antidepressant-like effects of a new dihydro isoquinoline and its chemical precursors in mice: involvement of serotonin and dopaminergic systemsCanadian Journal of Chemistry 2021; 99(5): 455 doi: 10.1139/cjc-2020-0291
Jing Sun, Fangyan Wang, Guangliang Hong, Mengqi Pang, Hailing Xu, Haixiao Li, Feng Tian, Renchi Fang, Ye Yao, Jiaming Liu. Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stressNeuroscience Letters 2016; 618: 159 doi: 10.1016/j.neulet.2016.03.003
Kunitoshi Kamijima, Moriyoshi Yasuda, Kayo Yamamura, Yasuhiko Fukuta. Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorderCurrent Medical Research and Opinion 2018; 34(12): 2105 doi: 10.1080/03007995.2018.1519317
Jan Wolff, Pamela Reißner, Gudrun Hefner, Claus Normann, Klaus Kaier, Harald Binder, Christoph Hiemke, Sermin Toto, Katharina Domschke, Michael Marschollek, Ansgar Klimke, Angela Lupattelli. Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disordersPLOS ONE 2021; 16(7): e0255192 doi: 10.1371/journal.pone.0255192
Aleksander A Mathé, Miranda Michaneck, Elisabeth Berg, Dennis S Charney, James W Murrough. A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive DisorderInternational Journal of Neuropsychopharmacology 2020; 23(12): 783 doi: 10.1093/ijnp/pyaa054
Miroslav Adzic, Iva Lukic, Milos Mitic, Emilija Glavonic, Nina Dragicevic, Sanja Ivkovic. Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamineLife Sciences 2023; 326: 121803 doi: 10.1016/j.lfs.2023.121803
Anna Camila Baioto Pina Reis, Eise Souza Do Vale, Rafaela Gonçalves Barbosa, Brenno Kristiano Soares Dos Santos, Yasmim Santos Da Silva, Leandro de Jesus Souza, Daiana de Freitas Ferreira Ramos, Amanda Florêncio Alves Silva, Eduardo da Silva Camargo, Letícia Corrêa Soares Suzart. AVALIAÇÃO PSIQUIÁTRICA DO PACIENTE COM DOENÇA DE PARKINSONRevista Contemporânea 2023; 3(10): 19105 doi: 10.56083/RCV3N10-133
Miranda Stiernborg, Paschalis Efstathopoulos, Andreas Lennartsson, Catharina Lavebratt, Aleksander A. Mathé. Sirtuins and neuropeptide y downregulation in Flinders Sensitive Line rat model of depressionActa Neuropsychiatrica 2022; 34(2): 86 doi: 10.1017/neu.2021.36
Reem M. Abuhejail, Nourah Z. Alzoman, Ibrahim A. Darwish. New Green and High-throughput Microwell Spectrophotometric Method for Quality Control of Pharmaceutical Formulations of Selective Serotonin Reuptake Inhibitors via Microscale Formation of their N-Vinylamino-naphthoquinone DerivativesCurrent Analytical Chemistry 2024; 20(1): 29 doi: 10.2174/0115734110281768231226115944
Phern Chern Tor, Nurmiati Amir, Johnson Fam, Roger Ho, Pichai Ittasakul, Margarita M Maramis, Benita Ponio, Dharmawan Ardi Purnama, Wanida Rattanasumawong, Elizabeth Rondain, Ahmad Hatim Bin Sulaiman, Kannokarn Wiroteurairuang, Kok Yoon Chee. A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant DepressionNeuropsychiatric Disease and Treatment 2022; : 2747 doi: 10.2147/NDT.S380792
Denis Sarrouilhe, Marc Mesnil, Catherine Dejean. Targeting Gap Junctions: New Insights into the Treatment of Major Depressive DisorderCurrent Medicinal Chemistry 2019; 26(20): 3775 doi: 10.2174/0929867325666180327103530
Elise Morlet, Jean-François Costemale-Lacoste, Emmanuel Poulet, Kibby McMahon, Nicolas Hoertel, Frédéric Limosin, J Adès, C Alezrah, I Amado, G Amar, O Andréi, D Arbault, G Archambault, G Aurifeuille, S Barrière, C Béra-Potelle, Y Blumenstock, H Bardou, M Bareil-Guérin, P Barrau, C Barrouillet, E Baup, N Bazin, B Beaufils, J Ben Ayed, M Benoit, K Benyacoub, T Bichet, F Blanadet, O Blanc, J Blanc-Comiti, D Boussiron, AM Bouysse, A Brochard, O Brochart, B Bucheron, M Cabot, V Camus, JM Chabannes, V Charlot, T Charpeaud, C Clad-Mor, C Combes, M Comisu, B Cordier, F Costi, JP Courcelles, M Creixell, H Cuche, C Cuervo-Lombard, A Dammak, D Da Rin, JB Denis, H Denizot, A Deperthuis, E Diers, S Dirami, D Donneau, P Dreano, C Dubertret, E Duprat, D Duthoit, C Fernandez, P Fonfrede, N Freitas, P Gasnier, J Gauillard, F Getten, F Gierski, F Godart, R Gourevitch, A Grassin Delyle, J Gremion, H Gres, V Griner, C Guerin-Langlois, C Guggiari, O Guillin, H Hadaoui, E Haffen, C Hanon, S Haouzir, C Hazif-Thomas, A Heron, B Hubsch, I Jalenques, D Januel, A Kaladjian, JF Karnycheff, O Kebir, MO Krebs, C Lajugie, M Leboyer, P Legrand, M Lejoyeux, V Lemaire, E Leroy, D Levy-Chavagnat, A Leydier, C Liling, PM Llorca, P Loeffel, P Louville, S Lucas Navarro, N Mages, M Mahi, O Maillet, A Manetti, C Martelli, P Martin, M Masson, I Maurs-Ferrer, J Mauvieux, S Mazmanian, E Mechin, L Mekaoui, M Meniai, A Metton, A Mihoubi, M Miron, G Mora, V Niro Adès, P Nubukpo, C Omnes, S Papin, P Paris, C Passerieux, J Pellerin, J Perlbarg, S Perron, A Petit, F Petitjean, C Portefaix, D Pringuey, A Radtchenko, H Rahiou, D Raucher-Chéné, A Rauzy, L Reinheimer, M Renard, M René, CE Rengade, P Reynaud, D Robin, C Rodrigues, A Rollet, F Rondepierre, B Rousselot, S Rubingher, G Saba, JP Salvarelli, JC Samuelian, C Scemama-Ammar, F Schurhoff, JP Schuster, D Sechter, B Segalas, T Seguret, AS Seigneurie, A Semmak, F Slama, S Taisne, M Taleb, JL Terra, D Thefenne, E Tran, R Tourtauchaux, MN Vacheron, P Vandel, V Vanhoucke, E Venet, H Verdoux, A Viala, G Vidon, M Vitre, JL Vurpas, C Wagermez, M Walter, L Yon, X. Zendjidjian. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter studyJournal of Affective Disorders 2019; 259: 210 doi: 10.1016/j.jad.2019.08.056
Francesco Angelucci, Bart A Ellenbroek, Aram El Khoury, Aleksander A. Mathé. CGRP in a gene–environment interaction model for depression: effects of antidepressant treatmentActa Neuropsychiatrica 2019; 31(2): 93 doi: 10.1017/neu.2018.31
Dmitry Frank, Benjamin F. Gruenbaum, Alexander Zlotnik, Michael Semyonov, Amit Frenkel, Matthew Boyko. Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A ReviewInternational Journal of Molecular Sciences 2022; 23(23): 15114 doi: 10.3390/ijms232315114
Dian-Jeng Li, Fu-Chiang Wang, Che-Sheng Chu, Tien-Yu Chen, Chia-Hung Tang, Wei-Cheng Yang, Philip Chik-keung Chow, Ching-Kuan Wu, Ping-Tao Tseng, Pao-Yen Lin. Significant treatment effect of add-on ketamine anesthesia in electroconvulsive therapy in depressive patients: A meta-analysisEuropean Neuropsychopharmacology 2017; 27(1): 29 doi: 10.1016/j.euroneuro.2016.11.008
Pasi Lampela, Antti Tanskanen, Markku Lähteenvuo, Jari Tiihonen, Heidi Taipale. Switches and early discontinuations of antidepressant medication in young adults with depressionJournal of Affective Disorders 2021; 295: 1474 doi: 10.1016/j.jad.2021.09.034